Anthropic's CEO channeled Elizabeth Holmes. The industry didn't hold back.

Anthropic CEO Dario Amodei, in a video tied to the company's upcoming IPO, made wildly optimistic claims about AI's ability to cure cancer and mental illness on unrealistic timelines. His statements were immediately compared to the fraudster Elizabeth Holmes by commentators and experts online. The pushback was swift, with prominent figures pointing out the fundamental challenges of medical research, data collection, and the non-negotiable timeframes of clinical trials that no AI can magically compress.

The response highlights a crucial moment for the AI industry: while promoting an IPO, a leader made claims so disconnected from scientific reality that they drew condemnation from across the medical community, including from Eli Lilly's CEO. This episode serves as a stark reminder that when tech hype ventures into life-and-death domains like medicine, the backlash isn't just about bad PR—it's about protecting public trust from what some are calling potential securities fraud. The takeaway: even in the age of AI, you can't algorithm your way around biology.